The store will not work correctly when cookies are disabled.
(S)-N-(4-(2-cyanopyrrolidine-1-carbonyl)phenyl)acetamide
ID: ALA4588524
PubChem CID: 155567204
Max Phase: Preclinical
Molecular Formula: C14H15N3O2
Molecular Weight: 257.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1ccc(C(=O)N2CCC[C@H]2C#N)cc1
Standard InChI: InChI=1S/C14H15N3O2/c1-10(18)16-12-6-4-11(5-7-12)14(19)17-8-2-3-13(17)9-15/h4-7,13H,2-3,8H2,1H3,(H,16,18)/t13-/m0/s1
Standard InChI Key: ZAXPUQJDDNSKSL-ZDUSSCGKSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
11.7694 -2.9633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7683 -3.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4805 -4.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1943 -3.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1914 -2.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4787 -2.5503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0575 -2.5508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3458 -2.9637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6338 -2.5511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3460 -3.7850 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9067 -4.1940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9080 -5.0153 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6179 -3.7843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3655 -4.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9113 -3.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5016 -2.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6985 -2.9662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3533 -4.9320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3452 -5.7497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
4 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
14 18 1 1
18 19 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 257.29 | Molecular Weight (Monoisotopic): 257.1164 | AlogP: 1.77 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.75 | CX Basic pKa: ┄ | CX LogP: 0.66 | CX LogD: 0.66 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.88 | Np Likeness Score: -1.33 |
References
1. Plescia J, Dufresne C, Janmamode N, Wahba AS, Mittermaier AK, Moitessier N.. (2020) Discovery of covalent prolyl oligopeptidase boronic ester inhibitors., 185 [PMID:31732257] [10.1016/j.ejmech.2019.111783] |